Clinical Trials on Immunotherapy, Active in Hong Kong
Total 9 results
-
Chinese University of Hong KongRecruitingActive Peptic Ulcer Disease/GI BleedingHong Kong
-
Chinese University of Hong KongCompletedGastrointestinal Bleeding | Bleeding Peptic Ulcer | Active BleedingChina
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong Kong; Alice Ho Miu Ling Nethersole HospitalCompletedTuberculosis, Pulmonary | Active Tuberculosis | Tuberculosis, ExtrapulmonaryHong Kong
-
Dr Joanne CHIURecruitingALK Gene Rearrangement Positive | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Activating Mutation | Nsclc | ROS1 Gene Rearrangement | ROS1 Positive NSCLC - Reactive Oxygen Species 1 Positive Non-Small Cell Lung CancerHong Kong
-
AstraZenecaActive, not recruitingActive Systemic Lupus ErythematosusThailand, Korea, Republic of, Philippines, China, Taiwan, Hong Kong
-
AmgenTerminatedActive Systemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, Canada, Spain, Italy, Mexico, Japan, Turkey, Austria, Greece, Colombia, Switzerland, Poland, France, Bulgaria, Hong Kong, Russian Federation, Chile
-
SunovionCompletedReactive Airways Disease (RAD)United States, Canada
-
MedAlliance, LLCNAMSARecruitingPeripheral Arterial Disease | Chronic Limb-Threatening Ischemia Nos of Native Arteries of ExtremitiesUnited States, Switzerland, New Zealand, Italy, Singapore, Hong Kong, Netherlands, France, Germany, Austria
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more